The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Neuronal vulnerability, pathogenesis, and Parkinson's disease
Open accessAbstract
Although there have been significant advances, pathogenesis in Parkinson's disease (PD) is still poorly understood. Potential clues about pathogenesis that have not been systematically pursued are suggested by the restricted pattern of neuronal pathology in the disease. In addition to dopaminergic neurons in the substantia nigra pars compacta (SNc), a significant number of other central and peripheral neuronal populations exhibit Lewy pathology (LP), phenotypic dysregulation, or frank degeneration in PD patients. Drawing on this literature, there appear to be a small number of risk factors contributing to vulnerability. These include autonomous activity, broad action potentials, low intrinsic calcium‐buffering capacity, poorly myelinated long highly branched axons and terminal fields, and use of a monoamine neurotransmitter, often with the catecholamine‐derived neuromelanin pigment. Of these phenotypic traits, only the physiological ones appear to provide a reachable therapeutic target at present. © 2013 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Aston-Jones, G., & Cohen, J. D. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135709 · Cited by 4,472
Second consensus statement on the diagnosis of multiple system atrophy
Gilman, S., Wenning, G. K., Low, P. A., Brooks, D. J., Mathias, C. J., Trojanowski, J. Q., Wood, N. W., Colosimo, C., Dürr, A., Fowler, C. J., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000324625.00404.15 · Cited by 3,140
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., & Finkbeiner, S. (2004) · Nature · doi:10.1038/nature02998 · Cited by 1,979
The substantia nigra of the human brain
Damier, P., Hirsch, E. C., Agid, Y., & Graybiel, A. M. (1999) · Brain · doi:10.1093/brain/122.8.1437 · Cited by 1,756
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
Self-citationBraak, H., de Vos, R. A. I., Bohl, J., & Del Tredici, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.012 · Cited by 1,354
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301 · cited 2×
“Although most obvious in the SNc and LC, NM is found in other central catecholamine neurons(37) and by more sensitive chemical methods in additional noncatecholaminergic neurons.(38,39) NM autophagic organelles are essentially identical to lipofuscin (LF) organelles, a different pigment derived from oxidized lipids an…”
Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
Nemani, V. M., Lu, W., Berge, V., Nakamura, K., Onoa, B., Lee, M. K., Chaudhry, F. A., Nicoll, R. A., & Edwards, R. H. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.023 · Cited by 1,056
Zarow, C., Lyness, S. A., Mortimer, J. A., & Chui, H. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.337 · Cited by 1,002
Description of Parkinson's Disease as a Clinical Syndrome
FAHN, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07458.x · Cited by 977
Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria
Dickson, D. W., Braak, H., Duda, J. E., Duyckaerts, C., Gasser, T., Halliday, G. M., Hardy, J., Leverenz, J. B., Del Tredici, K., Wszolek, Z. K., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70238-8 · Cited by 972
Matsuda, W., Furuta, T., Nakamura, K. C., Hioki, H., Fujiyama, F., Arai, R., & Kaneko, T. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4029-08.2009 · Cited by 865
Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1
Guzman, J. N., Sanchez-Padilla, J., Wokosin, D., Kondapalli, J., Ilijic, E., Schumacker, P. T., & Surmeier, D. J. (2010) · Nature · doi:10.1038/nature09536 · Cited by 843
Self-citationWhere Does Parkinson Disease Pathology Begin in the Brain?
Del Tredici, K., Rüb, U., de Vos, R. A. I., Bohl, J. R. E., & Braak, H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.5.413 · Cited by 773
Keeney, P. M., Xie, J., Capaldi, R. A., & Bennett, J. P. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0984-06.2006 · Cited by 747
Etiology and pathogenesis of Parkinson's disease
Schapira, A. H., & Jenner, P. (2011) · Movement Disorders · doi:10.1002/mds.23732 · Cited by 657
Nakamura, K., Nemani, V. M., Azarbal, F., Skibinski, G., Levy, J. M., Egami, K., Munishkina, L., Zhang, J., Gardner, B., Wakabayashi, J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213538 · Cited by 596
Hypocretin (orexin) cell loss in Parkinson's disease
Thannickal, T. C., Lai, Y.-Y., & Siegel, J. M. (2007) · Brain · doi:10.1093/brain/awm097 · Cited by 566
Hirsch, E. C., Graybiel, A. M., Duyckaerts, C., & Javoy-Agid, F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5976 · Cited by 554
Mosharov, E. V., Larsen, K. E., Kanter, E., Phillips, K. A., Wilson, K., Schmitz, Y., Krantz, D. E., Kobayashi, K., Edwards, R. H., & Sulzer, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.01.033 · Cited by 534
Self-citationParkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses
Wakabayashi, K., Takahashi, H., Takeda, S., Ohama, E., & Ikuta, F. (1988) · Acta Neuropathologica · doi:10.1007/bf00687767 · Cited by 528
THE BRAIN-STEM LESIONS IN PARKINSONISM
Greenfield, J. G., & Bosanquet, F. D. (1953) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.16.4.213 · Cited by 494
Orimo, S., Uchihara, T., Nakamura, A., Mori, F., Kakita, A., Wakabayashi, K., & Takahashi, H. (2008) · Brain · doi:10.1093/brain/awm302 · Cited by 462
Cubells, J., Rayport, S., Rajendran, G., & Sulzer, D. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-04-02260.1994 · Cited by 448
Self-citationLebouvier, T., Neunlist, M., Bruley des Varannes, S., Coron, E., Drouard, A., N'Guyen, J.-M., Chaumette, T., Tasselli, M., Paillusson, S., Flamand, M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012728 · Cited by 427
Larsen, K. E., Schmitz, Y., Troyer, M. D., Mosharov, E., Dietrich, P., Quazi, A. Z., Savalle, M., Nemani, V., Chaudhry, F. A., Edwards, R. H., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3821-06.2006 · Cited by 415
Self-citationNeuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease
Halliday, G. M., Li, Y. W., Blumbergs, P. C., Joh, T. H., Cotton, R. G. H., Howe, P. R. C., Blessing, W. W., & Geffen, L. B. (1990) · Annals of Neurology · doi:10.1002/ana.410270405 · Cited by 408
Sulzer, D., Bogulavsky, J., Larsen, K. E., Behr, G., Karatekin, E., Kleinman, M. H., Turro, N., Krantz, D., Edwards, R. H., Greene, L. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.11869 · Cited by 407
Self-citationLi, Z., Chalazonitis, A., Huang, Y.-Y., Mann, J. J., Margolis, K. G., Yang, Q. M., Kim, D. O., Cote, F., Mallet, J., & Gershon, M. D. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6684-10.2011 · Cited by 403
Jellinger, K. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.4.540 · Cited by 373
Singaram, C., Gaumnitz, E. A., Torbey, C., Ashraf, W., Quigley, E. M. M., Sengupta, A., & Pfeiffer, R. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92707-7 · Cited by 368
Membrane properties of rat locus coeruleus neurones
Williams, J. T., North, R. A., Shefner, S. A., Nishi, S., & Egan, T. M. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90265-3 · Cited by 341
Larsen, K. E., Fon, E. A., Hastings, T. G., Edwards, R. H., & Sulzer, D. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08951.2002 · Cited by 335
Self-citationWakabayashi, K., Takahashi, H., Ohama, E., & Ikuta, F. (1990) · Acta Neuropathologica · doi:10.1007/bf00294234 · Cited by 319
Esophageal Lewy bodies associated with ganglion cell loss in achalasia
Qualman, S. J., Haupt, H. M., Yang, P., & Hamilton, S. R. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90079-9 · Cited by 304
Neuroanatomy and Pathology of Sporadic Parkinson's Disease
(2008) · Advances in Anatomy, Embryology and Cell Biology · doi:10.1007/978-3-540-79850-7 · Cited by 297
Qualman, S. J., Haupt, H. M., Yang, P. H., & Hamilton, S. R. (1984) · PubMed · Cited by 295
Del Tredici, K., Hawkes, C. H., Ghebremedhin, E., & Braak, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0665-2 · Cited by 295
The anterior olfactory nucleus in Parkinson's disease
Pearce, R. K. B., Hawkes, C. H., & Daniel, S. E. (1995) · Movement Disorders · doi:10.1002/mds.870100309 · Cited by 290
Excitotoxicity and nitric oxide in parkinson's disease pathogenesis
Beal, M. F. (1998) · Annals of Neurology · doi:10.1002/ana.410440716 · Cited by 283
Chronic Constipation in the Elderly
Bouras, E. P., & Tangalos, E. G. (2009) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2009.06.001 · Cited by 275
L‐type calcium channel blockers and Parkinson disease in Denmark
Ritz, B., Rhodes, S. L., Qian, L., Schernhammer, E., Olsen, J. H., & Friis, S. (2010) · Annals of Neurology · doi:10.1002/ana.21937 · Cited by 273
Hydroxyl radical attack on dopamine.
Slivka, A., & Cohen, G. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36277-4 · Cited by 264
Zecca, L., Zucca, F. A., Wilms, H., & Sulzer, D. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.08.009 · Cited by 264
Self-citationThe second brain and Parkinson’s disease
Lebouvier, T., Chaumette, T., Paillusson, S., Duyckaerts, C., Bruley des Varannes, S., Neunlist, M., & Derkinderen, P. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06873.x · Cited by 261
Parkinson's disease: Neuron loss in the nucleus basalis without concomitant Alzheimer's disease
Nakano, I., & Hirano, A. (1984) · Annals of Neurology · doi:10.1002/ana.410150503 · Cited by 259
Zhang, W., Phillips, K., Wielgus, A. R., Liu, J., Albertini, A., Zucca, F. A., Faust, R., Qian, S. Y., Miller, D. S., Chignell, C. F., et al. (2011) · Neurotoxicity Research · doi:10.1007/s12640-009-9140-z · Cited by 257
Self-citationNeurodegeneration and neuroprotection in Parkinson disease
Fahn, S., & Sulzer, D. (2004) · NeuroRX · doi:10.1602/neurorx.1.1.139 · Cited by 257
Self-citationOrthostatic hypotension from sympathetic denervation in Parkinson’s disease
Goldstein, D. S., Holmes, C. S., Dendi, R., Bruce, S. R., & Li, S.-T. (2002) · Neurology · doi:10.1212/wnl.58.8.1247 · Cited by 257
Lewy body-related ?-synucleinopathy in the aged human brain
Jellinger, K. A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0138-7 · Cited by 256
Henderson, J. M. (2000) · Brain · doi:10.1093/brain/123.7.1410 · Cited by 244
Unregulated Cytosolic Dopamine Causes Neurodegeneration Associated with Oxidative Stress in Mice
Chen, L., Ding, Y., Cagniard, B., Van Laar, A. D., Mortimer, A., Chi, W., Hastings, T. G., Kang, U. J., & Zhuang, X. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3602-07.2008 · Cited by 239
Kupsky, W. J., Grimes, M. M., Sweeting, J., Bertsch, R., & Cote, L. J. (1987) · Neurology · doi:10.1212/wnl.37.7.1253 · Cited by 233
A critical evaluation of current staging of α-synuclein pathology in Lewy body disorders
Jellinger, K. A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.07.006 · Cited by 232
Use of antihypertensives and the risk of Parkinson disease
Becker, C., Jick, S. S., & Meier, C. R. (2008) · Neurology · doi:10.1212/01.wnl.0000303818.38960.44 · Cited by 230
Kalaitzakis, M. E., Graeber, M. B., Gentleman, S. M., & Pearce, R. K. B. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00923.x · Cited by 222
Travagli, R. A., Gillis, R. A., Rossiter, C. D., & Vicini, S. (1991) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1991.260.3.g531 · Cited by 213
Anlauf, M., Schäfer, M. K. ‐., Eiden, L., & Weihe, E. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10599 · Cited by 213
Expression and 1,4-Dihydropyridine-Binding Properties of Brain L-Type Calcium Channel Isoforms
Sinnegger-Brauns, M. J., Huber, I. G., Koschak, A., Wild, C., Obermair, G. J., Einzinger, U., Hoda, J.-C., Sartori, S. B., & Striessnig, J. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.049981 · Cited by 212
Overview of the Extranigral Aspects of Parkinson Disease
Lim, S.-Y., Fox, S. H., & Lang, A. E. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.561 · Cited by 207
Anatomy, physiology, and pathophysiology of the pedunculopontine nucleus
Jenkinson, N., Nandi, D., Muthusamy, K., Ray, N. J., Gregory, R., Stein, J. F., & Aziz, T. Z. (2009) · Movement Disorders · doi:10.1002/mds.22189 · Cited by 195
Sulzer, D., Mosharov, E., Talloczy, Z., Zucca, F. A., Simon, J. D., & Zecca, L. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05385.x · Cited by 191
Self-citationLiang, C.-L., Wang, T. T., Luby-Phelps, K., & German, D. C. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.015 · Cited by 185
Profound Cardiac Sympathetic Denervation Occurs in Parkinson Disease
Amino, T., Orimo, S., Itoh, Y., Takahashi, A., Uchihara, T., & Mizusawa, H. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00097.x · Cited by 183
Poor and protracted myelination as a contributory factor to neurodegenerative disorders
Braak, H., & Del Tredici, K. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.04.001 · Cited by 178
Rinne, J. O., Ma, S. Y., Lee, M. S., Collan, Y., & Röyttä, M. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.01.006 · Cited by 175
(1911) · Journal of the American Medical Association · doi:10.1001/jama.1911.02560030051032 · Cited by 175
Weihe, E., Depboylu, C., Schütz, B., Schäfer, M. K.-H., & Eiden, L. E. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9053-9 · Cited by 162
Spare respiratory capacity, oxidative stress and excitotoxicity
Nicholls, D. G. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371385 · Cited by 161
Raised calcium promotes α-synuclein aggregate formation
Nath, S., Goodwin, J., Engelborghs, Y., & Pountney, D. L. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.12.004 · Cited by 154
Cersosimo, M. G., & Benarroch, E. E. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.09.030 · Cited by 153
Dopamine-modified α-synuclein blocks chaperone-mediated autophagy
Martinez-Vicente, M., Talloczy, Z., Kaushik, S., Massey, A. C., Mazzulli, J., Mosharov, E. V., Hodara, R., Fredenburg, R., Wu, D.-C., Follenzi, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32806 · Cited by 144
Self-citationThe Origins of Oxidant Stress in Parkinson's Disease and Therapeutic Strategies
Surmeier, D. J., Guzmán, J. N., Sánchez-Padilla, J., & Goldberg, J. A. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3521 · Cited by 142
Self-citationSpecific A10 Dopaminergic Nuclei in the Midbrain Degenerate in Parkinson's Disease
McRitchie, D. A., Cartwright, H., & Halliday, G. M. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6418 · Cited by 138
Serafin, M., Khateb, A., & Mühlethaler, M. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90154-2 · Cited by 135
Fumimura, Y., Ikemura, M., Saito, Y., Sengoku, R., Kanemaru, K., Sawabe, M., Arai, T., Ito, G., Iwatsubo, T., Fukayama, M., et al. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3180517454 · Cited by 134
Endogenous Calcium Buffering Capacity of Substantia Nigral Dopamine Neurons
Foehring, R. C., Zhang, X. F., Lee, J. C. F., & Callaway, J. C. (2009) · Journal of Neurophysiology · doi:10.1152/jn.00038.2009 · Cited by 127
Characterization of Myenteric Sensory Neurons in the Mouse Small Intestine
Mao, Y., Wang, B., & Kunze, W. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00204.2006 · Cited by 124
Oxytocin excites gastric-related neurones in rat dorsal vagal complex
McCann, M. J., & Rogers, R. C. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018202 · Cited by 118
Liang, C., Nelson, O. L., Yazdani, U., Pasbakhsh, P., & German, D. C. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20098 · Cited by 117
Liang, C., Sinton, C. M., Sonsalla, P. K., & German, D. C. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0042 · Cited by 116
Clinical availability of skin biopsy in the diagnosis of Parkinson's disease
Miki, Y., Tomiyama, M., Ueno, T., Haga, R., Nishijima, H., Suzuki, C., Mori, F., Kaimori, M., Baba, M., & Wakabayashi, K. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.12.027 · Cited by 114
Weihe, E., Schütz, B., Hartschuh, W., Anlauf, M., Schäfer, M. K.-H., & Eiden, L. E. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20745 · Cited by 108
CORRESPONDENCE OF MELANIN-PIGMENTED NEURONS IN HUMAN BRAIN WITH A1–A14 CATECHOLAMINE CELL ROUPS
SAPER, C. B., & PETITO, C. K. (1982) · Brain · doi:10.1093/brain/105.1.87 · Cited by 107
Úbeda‐Bañón, I., Saiz‐Sánchez, D., de la Rosa‐Prieto, C., Argandoña‐Palacios, L., García-Muñozguren, S., & Martínez-Marcos, A. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0687-9 · Cited by 97
THE PATHOLOGY OF CERTAIN MEDULLARY NUCLEI IN PARKINSONISM
Eadie, M. J. (1963) · Brain · doi:10.1093/brain/86.4.781 · Cited by 96
Huisman, E., Uylings, H. B. M., & Hoogland, P. V. J. M. (2008) · Movement Disorders · doi:10.1002/mds.22009 · Cited by 95
Phenotypic Differentiation during Migration of Dopaminergic Progenitor Cells to the Olfactory Bulb
Baker, H. A., Liu, N., Chun, H. S., Saino‐Saito, S., Berlin, R., Volpe, B. T., & Son, J. H. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08505.2001 · Cited by 94
GAI, W. P., Halliday, G. M., Blumbergs, P. C., Geffen, L. B., & Blessing, W. W. (1991) · Brain · doi:10.1093/brain/114.5.2253 · Cited by 89
The black stuff and Konstantin Nikolaevich Tretiakoff
Lees, A. J., Selikhova, M. V., de Andrade, L. A. F., & Duyckaerts, C. J. (2008) · Movement Disorders · doi:10.1002/mds.21855 · Cited by 88
Medullary catecholaminergic neurons in the normal human brain and in Parkinson's disease
Saper, C. B., Sorrentino, D. M., German, D. C., & Lacalle, S. D. (1991) · Annals of Neurology · doi:10.1002/ana.410290602 · Cited by 87
Age-related loss of dorsal vagal neurons in Parkinson's disease
Gai, W., Blumbergs, P. C., Geffen, L. B., & Blessing, W. W. (1992) · Neurology · doi:10.1212/wnl.42.11.2106 · Cited by 85
Analysis of Whole-cell Currents by Patch Clamp of Guinea-pig Myenteric Neurones in Intact Ganglia
Rugiero, F., Gola, M., Kunze, W. A. A., Reynaud, J., Furness, J. B., & Clerc, N. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2001.013051 · Cited by 79
Clerc, N., Furness, J. B., Bornstein, J. C., & Kunze, W. A. A. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00318-7 · Cited by 75
Ghebremedhin, E., Tredici, K. D., Langston, J. W., & Braak, H. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0596-y · Cited by 74
Histochemistry of Adrenal Bodies in Parkinson's Disease
Jager, W. A. D. H. (1970) · Archives of Neurology · doi:10.1001/archneur.1970.00480300050006 · Cited by 74
Lewy bodies and olfactory dysfunction in old age.
Wilson, R. S., Yu, L., Schneider, J., Arnold, S., Buchman, A., & Bennett, D. (2011) · Chemical Sensors · doi:10.1093/chemse/bjq139 · Cited by 72
Lesions outside the CNS in Parkinson's disease
Djaldetti, R., Lev, N., & Melamed, E. (2009) · Movement Disorders · doi:10.1002/mds.22172 · Cited by 70
A not entirely benign procedure: progression of Parkinson’s disease
Tredici, K. D., & Braak, H. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0355-5 · Cited by 67
Parkinson's disease with involvement of the parasympathetic ganglia
Takeda, S., Yamazaki, K., Miyakawa, T., & Arai, H. (1993) · Acta Neuropathologica · doi:10.1007/bf00369454 · Cited by 63
Orimo, S., Uchihara, T., Kanazawa, T., Itoh, Y., Wakabayashi, K., Kakita, A., & Takahashi, H. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01194.x · Cited by 62
Clerc, N., Furness, J. B., Li, Z. S., Bornstein, J. C., & Kunze, W. A. A. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00025-6 · Cited by 61
Cullen, K. M., & Halliday, G. M. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00066-9 · Cited by 59
Intrinsic Bioenergetic Properties and Stress Sensitivity of Dopaminergic Synaptosomes
Choi, S. W., Gerencser, A. A., Lee, D. W., Rajagopalan, S., Nicholls, D. G., Andersen, J. K., & Brand, M. D. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5817-10.2011 · Cited by 51
Dugger, B. N., & Dickson, D. W. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0739-1 · Cited by 49
Tamura, K., Ito, H., & Wade, P. R. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1293 · Cited by 33
Szegő, É. M., Gerhardt, E., Outeiro, T. F., & Kermer, P. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.06.048 · Cited by 29
Chan, J. Y. H., & Chan, S. H. H. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90158-4 · Cited by 8
Retinal dopamine sensitivity to MPP+ toxicity: electrophysiological and biochemical evaluation
Harnois, C., Marcotte, G., Daigle, M., & Paolo, T. D. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90784-2 · Cited by 6
Cited by
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
Selective neuronal vulnerability in Parkinson disease
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,116
Self-citationα-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
Wong, Y. C., & Krainc, D. (2017) · Nature Medicine · doi:10.1038/nm.4269 · Cited by 897
Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF
Fischer, R., & Maier, O. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/610813 · Cited by 731
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659
Self-citation
Metadata
- Authors
- Sulzer, D., & Surmeier, D. J.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2012-07-12
- Volume
- 28
- Issue
- 1
- Pages
- 41-50
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2148214085
- Cited by
- 315
- References
- 112
- FWCI
- 13.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.